# DESVENLAFAXINE SUCCINATE
> **ANDA211427** · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2025-01-15
## Drug
- **FDA Application Number:** ANDA211427
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DESVENLAFAXINE SUCCINATE
- **Generic name:** DESVENLAFAXINE SUCCINATE
- **Active ingredients:** DESVENLAFAXINE SUCCINATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MACLEODS PHARMS LTD
- **Manufacturer:** Macleods Pharmaceuticals Limited
- **First approval:** 2025-01-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211427)
---
*AI Analytics · CC0 1.0*